[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Dementia and Alzheimer’s Disease Treatment Market Research Report 2024(Status and Outlook)

July 2024 | 124 pages | ID: G3BB1C162157EN
Bosson Research

US$ 3,200.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Overview:

Alzheimer’s disease is a chronic neurodegenerative disorder which results in gradual degradation of the tissues of the brain. This hampers the normal functioning of the brain and impacts the daily lives of patients.

The Global Dementia and Alzheimer’s Disease Treatment Market Size was estimated at USD 3725.43 million in 2023 and is projected to reach USD 4320.35 million by 2029, exhibiting a CAGR of 2.50% during the forecast period.

This report provides a deep insight into the global Dementia and Alzheimer’s Disease Treatment market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Dementia and Alzheimer’s Disease Treatment Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Dementia and Alzheimer’s Disease Treatment market in any manner.

Global Dementia and Alzheimer’s Disease Treatment Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Novartis

Pfizer, Inc.

AbbVie Inc.

Allergan plc

Eli Lilly and Company

F. Hoffmann-La Roche Ltd.

AstraZeneca

Biogen

Eisai Co., Ltd.

INmuneBIO

Market Segmentation (by Type)

Cholinesterase Inhibitors

Memantine

Combination Drugs

Market Segmentation (by Application)

Hospital

Clinic

Geographic Segmentation
  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Dementia and Alzheimer’s Disease Treatment Market
  • Overview of the regional outlook of the Dementia and Alzheimer’s Disease Treatment Market:
Key Reasons to Buy this Report:
  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Note: this report may need to undergo a final check or review and this could take about 48 hours.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Dementia and Alzheimer’s Disease Treatment Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Dementia and Alzheimer’s Disease Treatment
1.2 Key Market Segments
  1.2.1 Dementia and Alzheimer’s Disease Treatment Segment by Type
  1.2.2 Dementia and Alzheimer’s Disease Treatment Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 DEMENTIA AND ALZHEIMER’S DISEASE TREATMENT MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Dementia and Alzheimer’s Disease Treatment Market Size (M USD) Estimates and Forecasts (2019-2030)
  2.1.2 Global Dementia and Alzheimer’s Disease Treatment Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 DEMENTIA AND ALZHEIMER’S DISEASE TREATMENT MARKET COMPETITIVE LANDSCAPE

3.1 Global Dementia and Alzheimer’s Disease Treatment Sales by Manufacturers (2019-2024)
3.2 Global Dementia and Alzheimer’s Disease Treatment Revenue Market Share by Manufacturers (2019-2024)
3.3 Dementia and Alzheimer’s Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Dementia and Alzheimer’s Disease Treatment Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Dementia and Alzheimer’s Disease Treatment Sales Sites, Area Served, Product Type
3.6 Dementia and Alzheimer’s Disease Treatment Market Competitive Situation and Trends
  3.6.1 Dementia and Alzheimer’s Disease Treatment Market Concentration Rate
  3.6.2 Global 5 and 10 Largest Dementia and Alzheimer’s Disease Treatment Players Market Share by Revenue
  3.6.3 Mergers & Acquisitions, Expansion

4 DEMENTIA AND ALZHEIMER’S DISEASE TREATMENT INDUSTRY CHAIN ANALYSIS

4.1 Dementia and Alzheimer’s Disease Treatment Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF DEMENTIA AND ALZHEIMER’S DISEASE TREATMENT MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
  5.5.1 New Product Developments
  5.5.2 Mergers & Acquisitions
  5.5.3 Expansions
  5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies

6 DEMENTIA AND ALZHEIMER’S DISEASE TREATMENT MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Dementia and Alzheimer’s Disease Treatment Sales Market Share by Type (2019-2024)
6.3 Global Dementia and Alzheimer’s Disease Treatment Market Size Market Share by Type (2019-2024)
6.4 Global Dementia and Alzheimer’s Disease Treatment Price by Type (2019-2024)

7 DEMENTIA AND ALZHEIMER’S DISEASE TREATMENT MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Dementia and Alzheimer’s Disease Treatment Market Sales by Application (2019-2024)
7.3 Global Dementia and Alzheimer’s Disease Treatment Market Size (M USD) by Application (2019-2024)
7.4 Global Dementia and Alzheimer’s Disease Treatment Sales Growth Rate by Application (2019-2024)

8 DEMENTIA AND ALZHEIMER’S DISEASE TREATMENT MARKET SEGMENTATION BY REGION

8.1 Global Dementia and Alzheimer’s Disease Treatment Sales by Region
  8.1.1 Global Dementia and Alzheimer’s Disease Treatment Sales by Region
  8.1.2 Global Dementia and Alzheimer’s Disease Treatment Sales Market Share by Region
8.2 North America
  8.2.1 North America Dementia and Alzheimer’s Disease Treatment Sales by Country
  8.2.2 U.S.
  8.2.3 Canada
  8.2.4 Mexico
8.3 Europe
  8.3.1 Europe Dementia and Alzheimer’s Disease Treatment Sales by Country
  8.3.2 Germany
  8.3.3 France
  8.3.4 U.K.
  8.3.5 Italy
  8.3.6 Russia
8.4 Asia Pacific
  8.4.1 Asia Pacific Dementia and Alzheimer’s Disease Treatment Sales by Region
  8.4.2 China
  8.4.3 Japan
  8.4.4 South Korea
  8.4.5 India
  8.4.6 Southeast Asia
8.5 South America
  8.5.1 South America Dementia and Alzheimer’s Disease Treatment Sales by Country
  8.5.2 Brazil
  8.5.3 Argentina
  8.5.4 Columbia
8.6 Middle East and Africa
  8.6.1 Middle East and Africa Dementia and Alzheimer’s Disease Treatment Sales by Region
  8.6.2 Saudi Arabia
  8.6.3 UAE
  8.6.4 Egypt
  8.6.5 Nigeria
  8.6.6 South Africa

9 KEY COMPANIES PROFILE

9.1 Novartis
  9.1.1 Novartis Dementia and Alzheimer’s Disease Treatment Basic Information
  9.1.2 Novartis Dementia and Alzheimer’s Disease Treatment Product Overview
  9.1.3 Novartis Dementia and Alzheimer’s Disease Treatment Product Market Performance
  9.1.4 Novartis Business Overview
  9.1.5 Novartis Dementia and Alzheimer’s Disease Treatment SWOT Analysis
  9.1.6 Novartis Recent Developments
9.2 Pfizer, Inc.
  9.2.1 Pfizer, Inc. Dementia and Alzheimer’s Disease Treatment Basic Information
  9.2.2 Pfizer, Inc. Dementia and Alzheimer’s Disease Treatment Product Overview
  9.2.3 Pfizer, Inc. Dementia and Alzheimer’s Disease Treatment Product Market Performance
  9.2.4 Pfizer, Inc. Business Overview
  9.2.5 Pfizer, Inc. Dementia and Alzheimer’s Disease Treatment SWOT Analysis
  9.2.6 Pfizer, Inc. Recent Developments
9.3 AbbVie Inc.
  9.3.1 AbbVie Inc. Dementia and Alzheimer’s Disease Treatment Basic Information
  9.3.2 AbbVie Inc. Dementia and Alzheimer’s Disease Treatment Product Overview
  9.3.3 AbbVie Inc. Dementia and Alzheimer’s Disease Treatment Product Market Performance
  9.3.4 AbbVie Inc. Dementia and Alzheimer’s Disease Treatment SWOT Analysis
  9.3.5 AbbVie Inc. Business Overview
  9.3.6 AbbVie Inc. Recent Developments
9.4 Allergan plc
  9.4.1 Allergan plc Dementia and Alzheimer’s Disease Treatment Basic Information
  9.4.2 Allergan plc Dementia and Alzheimer’s Disease Treatment Product Overview
  9.4.3 Allergan plc Dementia and Alzheimer’s Disease Treatment Product Market Performance
  9.4.4 Allergan plc Business Overview
  9.4.5 Allergan plc Recent Developments
9.5 Eli Lilly and Company
  9.5.1 Eli Lilly and Company Dementia and Alzheimer’s Disease Treatment Basic Information
  9.5.2 Eli Lilly and Company Dementia and Alzheimer’s Disease Treatment Product Overview
  9.5.3 Eli Lilly and Company Dementia and Alzheimer’s Disease Treatment Product Market Performance
  9.5.4 Eli Lilly and Company Business Overview
  9.5.5 Eli Lilly and Company Recent Developments
9.6 F. Hoffmann-La Roche Ltd.
  9.6.1 F. Hoffmann-La Roche Ltd. Dementia and Alzheimer’s Disease Treatment Basic Information
  9.6.2 F. Hoffmann-La Roche Ltd. Dementia and Alzheimer’s Disease Treatment Product Overview
  9.6.3 F. Hoffmann-La Roche Ltd. Dementia and Alzheimer’s Disease Treatment Product Market Performance
  9.6.4 F. Hoffmann-La Roche Ltd. Business Overview
  9.6.5 F. Hoffmann-La Roche Ltd. Recent Developments
9.7 AstraZeneca
  9.7.1 AstraZeneca Dementia and Alzheimer’s Disease Treatment Basic Information
  9.7.2 AstraZeneca Dementia and Alzheimer’s Disease Treatment Product Overview
  9.7.3 AstraZeneca Dementia and Alzheimer’s Disease Treatment Product Market Performance
  9.7.4 AstraZeneca Business Overview
  9.7.5 AstraZeneca Recent Developments
9.8 Biogen
  9.8.1 Biogen Dementia and Alzheimer’s Disease Treatment Basic Information
  9.8.2 Biogen Dementia and Alzheimer’s Disease Treatment Product Overview
  9.8.3 Biogen Dementia and Alzheimer’s Disease Treatment Product Market Performance
  9.8.4 Biogen Business Overview
  9.8.5 Biogen Recent Developments
9.9 Eisai Co., Ltd.
  9.9.1 Eisai Co., Ltd. Dementia and Alzheimer’s Disease Treatment Basic Information
  9.9.2 Eisai Co., Ltd. Dementia and Alzheimer’s Disease Treatment Product Overview
  9.9.3 Eisai Co., Ltd. Dementia and Alzheimer’s Disease Treatment Product Market Performance
  9.9.4 Eisai Co., Ltd. Business Overview
  9.9.5 Eisai Co., Ltd. Recent Developments
9.10 INmuneBIO
  9.10.1 INmuneBIO Dementia and Alzheimer’s Disease Treatment Basic Information
  9.10.2 INmuneBIO Dementia and Alzheimer’s Disease Treatment Product Overview
  9.10.3 INmuneBIO Dementia and Alzheimer’s Disease Treatment Product Market Performance
  9.10.4 INmuneBIO Business Overview
  9.10.5 INmuneBIO Recent Developments

10 DEMENTIA AND ALZHEIMER’S DISEASE TREATMENT MARKET FORECAST BY REGION

10.1 Global Dementia and Alzheimer’s Disease Treatment Market Size Forecast
10.2 Global Dementia and Alzheimer’s Disease Treatment Market Forecast by Region
  10.2.1 North America Market Size Forecast by Country
  10.2.2 Europe Dementia and Alzheimer’s Disease Treatment Market Size Forecast by Country
  10.2.3 Asia Pacific Dementia and Alzheimer’s Disease Treatment Market Size Forecast by Region
  10.2.4 South America Dementia and Alzheimer’s Disease Treatment Market Size Forecast by Country
  10.2.5 Middle East and Africa Forecasted Consumption of Dementia and Alzheimer’s Disease Treatment by Country

11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)

11.1 Global Dementia and Alzheimer’s Disease Treatment Market Forecast by Type (2025-2030)
  11.1.1 Global Forecasted Sales of Dementia and Alzheimer’s Disease Treatment by Type (2025-2030)
  11.1.2 Global Dementia and Alzheimer’s Disease Treatment Market Size Forecast by Type (2025-2030)
  11.1.3 Global Forecasted Price of Dementia and Alzheimer’s Disease Treatment by Type (2025-2030)
11.2 Global Dementia and Alzheimer’s Disease Treatment Market Forecast by Application (2025-2030)
  11.2.1 Global Dementia and Alzheimer’s Disease Treatment Sales (Kilotons) Forecast by Application
  11.2.2 Global Dementia and Alzheimer’s Disease Treatment Market Size (M USD) Forecast by Application (2025-2030)

12 CONCLUSION AND KEY FINDINGS

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Dementia and Alzheimer’s Disease Treatment Market Size Comparison by Region (M USD)
Table 5. Global Dementia and Alzheimer’s Disease Treatment Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Dementia and Alzheimer’s Disease Treatment Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Dementia and Alzheimer’s Disease Treatment Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Dementia and Alzheimer’s Disease Treatment Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dementia and Alzheimer’s Disease Treatment as of 2022)
Table 10. Global Market Dementia and Alzheimer’s Disease Treatment Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Dementia and Alzheimer’s Disease Treatment Sales Sites and Area Served
Table 12. Manufacturers Dementia and Alzheimer’s Disease Treatment Product Type
Table 13. Global Dementia and Alzheimer’s Disease Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Dementia and Alzheimer’s Disease Treatment
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Dementia and Alzheimer’s Disease Treatment Market Challenges
Table 22. Global Dementia and Alzheimer’s Disease Treatment Sales by Type (Kilotons)
Table 23. Global Dementia and Alzheimer’s Disease Treatment Market Size by Type (M USD)
Table 24. Global Dementia and Alzheimer’s Disease Treatment Sales (Kilotons) by Type (2019-2024)
Table 25. Global Dementia and Alzheimer’s Disease Treatment Sales Market Share by Type (2019-2024)
Table 26. Global Dementia and Alzheimer’s Disease Treatment Market Size (M USD) by Type (2019-2024)
Table 27. Global Dementia and Alzheimer’s Disease Treatment Market Size Share by Type (2019-2024)
Table 28. Global Dementia and Alzheimer’s Disease Treatment Price (USD/Ton) by Type (2019-2024)
Table 29. Global Dementia and Alzheimer’s Disease Treatment Sales (Kilotons) by Application
Table 30. Global Dementia and Alzheimer’s Disease Treatment Market Size by Application
Table 31. Global Dementia and Alzheimer’s Disease Treatment Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Dementia and Alzheimer’s Disease Treatment Sales Market Share by Application (2019-2024)
Table 33. Global Dementia and Alzheimer’s Disease Treatment Sales by Application (2019-2024) & (M USD)
Table 34. Global Dementia and Alzheimer’s Disease Treatment Market Share by Application (2019-2024)
Table 35. Global Dementia and Alzheimer’s Disease Treatment Sales Growth Rate by Application (2019-2024)
Table 36. Global Dementia and Alzheimer’s Disease Treatment Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Dementia and Alzheimer’s Disease Treatment Sales Market Share by Region (2019-2024)
Table 38. North America Dementia and Alzheimer’s Disease Treatment Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Dementia and Alzheimer’s Disease Treatment Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Dementia and Alzheimer’s Disease Treatment Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Dementia and Alzheimer’s Disease Treatment Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Dementia and Alzheimer’s Disease Treatment Sales by Region (2019-2024) & (Kilotons)
Table 43. Novartis Dementia and Alzheimer’s Disease Treatment Basic Information
Table 44. Novartis Dementia and Alzheimer’s Disease Treatment Product Overview
Table 45. Novartis Dementia and Alzheimer’s Disease Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Novartis Business Overview
Table 47. Novartis Dementia and Alzheimer’s Disease Treatment SWOT Analysis
Table 48. Novartis Recent Developments
Table 49. Pfizer, Inc. Dementia and Alzheimer’s Disease Treatment Basic Information
Table 50. Pfizer, Inc. Dementia and Alzheimer’s Disease Treatment Product Overview
Table 51. Pfizer, Inc. Dementia and Alzheimer’s Disease Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Pfizer, Inc. Business Overview
Table 53. Pfizer, Inc. Dementia and Alzheimer’s Disease Treatment SWOT Analysis
Table 54. Pfizer, Inc. Recent Developments
Table 55. AbbVie Inc. Dementia and Alzheimer’s Disease Treatment Basic Information
Table 56. AbbVie Inc. Dementia and Alzheimer’s Disease Treatment Product Overview
Table 57. AbbVie Inc. Dementia and Alzheimer’s Disease Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. AbbVie Inc. Dementia and Alzheimer’s Disease Treatment SWOT Analysis
Table 59. AbbVie Inc. Business Overview
Table 60. AbbVie Inc. Recent Developments
Table 61. Allergan plc Dementia and Alzheimer’s Disease Treatment Basic Information
Table 62. Allergan plc Dementia and Alzheimer’s Disease Treatment Product Overview
Table 63. Allergan plc Dementia and Alzheimer’s Disease Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Allergan plc Business Overview
Table 65. Allergan plc Recent Developments
Table 66. Eli Lilly and Company Dementia and Alzheimer’s Disease Treatment Basic Information
Table 67. Eli Lilly and Company Dementia and Alzheimer’s Disease Treatment Product Overview
Table 68. Eli Lilly and Company Dementia and Alzheimer’s Disease Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Eli Lilly and Company Business Overview
Table 70. Eli Lilly and Company Recent Developments
Table 71. F. Hoffmann-La Roche Ltd. Dementia and Alzheimer’s Disease Treatment Basic Information
Table 72. F. Hoffmann-La Roche Ltd. Dementia and Alzheimer’s Disease Treatment Product Overview
Table 73. F. Hoffmann-La Roche Ltd. Dementia and Alzheimer’s Disease Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. F. Hoffmann-La Roche Ltd. Business Overview
Table 75. F. Hoffmann-La Roche Ltd. Recent Developments
Table 76. AstraZeneca Dementia and Alzheimer’s Disease Treatment Basic Information
Table 77. AstraZeneca Dementia and Alzheimer’s Disease Treatment Product Overview
Table 78. AstraZeneca Dementia and Alzheimer’s Disease Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. AstraZeneca Business Overview
Table 80. AstraZeneca Recent Developments
Table 81. Biogen Dementia and Alzheimer’s Disease Treatment Basic Information
Table 82. Biogen Dementia and Alzheimer’s Disease Treatment Product Overview
Table 83. Biogen Dementia and Alzheimer’s Disease Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Biogen Business Overview
Table 85. Biogen Recent Developments
Table 86. Eisai Co., Ltd. Dementia and Alzheimer’s Disease Treatment Basic Information
Table 87. Eisai Co., Ltd. Dementia and Alzheimer’s Disease Treatment Product Overview
Table 88. Eisai Co., Ltd. Dementia and Alzheimer’s Disease Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Eisai Co., Ltd. Business Overview
Table 90. Eisai Co., Ltd. Recent Developments
Table 91. INmuneBIO Dementia and Alzheimer’s Disease Treatment Basic Information
Table 92. INmuneBIO Dementia and Alzheimer’s Disease Treatment Product Overview
Table 93. INmuneBIO Dementia and Alzheimer’s Disease Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. INmuneBIO Business Overview
Table 95. INmuneBIO Recent Developments
Table 96. Global Dementia and Alzheimer’s Disease Treatment Sales Forecast by Region (2025-2030) & (Kilotons)
Table 97. Global Dementia and Alzheimer’s Disease Treatment Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America Dementia and Alzheimer’s Disease Treatment Sales Forecast by Country (2025-2030) & (Kilotons)
Table 99. North America Dementia and Alzheimer’s Disease Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe Dementia and Alzheimer’s Disease Treatment Sales Forecast by Country (2025-2030) & (Kilotons)
Table 101. Europe Dementia and Alzheimer’s Disease Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific Dementia and Alzheimer’s Disease Treatment Sales Forecast by Region (2025-2030) & (Kilotons)
Table 103. Asia Pacific Dementia and Alzheimer’s Disease Treatment Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America Dementia and Alzheimer’s Disease Treatment Sales Forecast by Country (2025-2030) & (Kilotons)
Table 105. South America Dementia and Alzheimer’s Disease Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa Dementia and Alzheimer’s Disease Treatment Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa Dementia and Alzheimer’s Disease Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global Dementia and Alzheimer’s Disease Treatment Sales Forecast by Type (2025-2030) & (Kilotons)
Table 109. Global Dementia and Alzheimer’s Disease Treatment Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global Dementia and Alzheimer’s Disease Treatment Price Forecast by Type (2025-2030) & (USD/Ton)
Table 111. Global Dementia and Alzheimer’s Disease Treatment Sales (Kilotons) Forecast by Application (2025-2030)
Table 112. Global Dementia and Alzheimer’s Disease Treatment Market Size Forecast by Application (2025-2030) & (M USD)

LIST OF FIGURES

Figure 1. Product Picture of Dementia and Alzheimer’s Disease Treatment
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Dementia and Alzheimer’s Disease Treatment Market Size (M USD), 2019-2030
Figure 5. Global Dementia and Alzheimer’s Disease Treatment Market Size (M USD) (2019-2030)
Figure 6. Global Dementia and Alzheimer’s Disease Treatment Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Dementia and Alzheimer’s Disease Treatment Market Size by Country (M USD)
Figure 11. Dementia and Alzheimer’s Disease Treatment Sales Share by Manufacturers in 2023
Figure 12. Global Dementia and Alzheimer’s Disease Treatment Revenue Share by Manufacturers in 2023
Figure 13. Dementia and Alzheimer’s Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Dementia and Alzheimer’s Disease Treatment Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Dementia and Alzheimer’s Disease Treatment Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Dementia and Alzheimer’s Disease Treatment Market Share by Type
Figure 18. Sales Market Share of Dementia and Alzheimer’s Disease Treatment by Type (2019-2024)
Figure 19. Sales Market Share of Dementia and Alzheimer’s Disease Treatment by Type in 2023
Figure 20. Market Size Share of Dementia and Alzheimer’s Disease Treatment by Type (2019-2024)
Figure 21. Market Size Market Share of Dementia and Alzheimer’s Disease Treatment by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Dementia and Alzheimer’s Disease Treatment Market Share by Application
Figure 24. Global Dementia and Alzheimer’s Disease Treatment Sales Market Share by Application (2019-2024)
Figure 25. Global Dementia and Alzheimer’s Disease Treatment Sales Market Share by Application in 2023
Figure 26. Global Dementia and Alzheimer’s Disease Treatment Market Share by Application (2019-2024)
Figure 27. Global Dementia and Alzheimer’s Disease Treatment Market Share by Application in 2023
Figure 28. Global Dementia and Alzheimer’s Disease Treatment Sales Growth Rate by Application (2019-2024)
Figure 29. Global Dementia and Alzheimer’s Disease Treatment Sales Market Share by Region (2019-2024)
Figure 30. North America Dementia and Alzheimer’s Disease Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Dementia and Alzheimer’s Disease Treatment Sales Market Share by Country in 2023
Figure 32. U.S. Dementia and Alzheimer’s Disease Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Dementia and Alzheimer’s Disease Treatment Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Dementia and Alzheimer’s Disease Treatment Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Dementia and Alzheimer’s Disease Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Dementia and Alzheimer’s Disease Treatment Sales Market Share by Country in 2023
Figure 37. Germany Dementia and Alzheimer’s Disease Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Dementia and Alzheimer’s Disease Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Dementia and Alzheimer’s Disease Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Dementia and Alzheimer’s Disease Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Dementia and Alzheimer’s Disease Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Dementia and Alzheimer’s Disease Treatment Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Dementia and Alzheimer’s Disease Treatment Sales Market Share by Region in 2023
Figure 44. China Dementia and Alzheimer’s Disease Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Dementia and Alzheimer’s Disease Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Dementia and Alzheimer’s Disease Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Dementia and Alzheimer’s Disease Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Dementia and Alzheimer’s Disease Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Dementia and Alzheimer’s Disease Treatment Sales and Growth Rate (Kilotons)
Figure 50. South America Dementia and Alzheimer’s Disease Treatment Sales Market Share by Country in 2023
Figure 51. Brazil Dementia and Alzheimer’s Disease Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Dementia and Alzheimer’s Disease Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Dementia and Alzheimer’s Disease Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Dementia and Alzheimer’s Disease Treatment Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Dementia and Alzheimer’s Disease Treatment Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Dementia and Alzheimer’s Disease Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Dementia and Alzheimer’s Disease Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Dementia and Alzheimer’s Disease Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Dementia and Alzheimer’s Disease Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Dementia and Alzheimer’s Disease Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Dementia and Alzheimer’s Disease Treatment Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Dementia and Alzheimer’s Disease Treatment Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Dementia and Alzheimer’s Disease Treatment Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Dementia and Alzheimer’s Disease Treatment Market Share Forecast by Type (2025-2030)
Figure 65. Global Dementia and Alzheimer’s Disease Treatment Sales Forecast by Application (2025-2030)
Figure 66. Global Dementia and Alzheimer’s Disease Treatment Market Share Forecast by Application (2025-2030)


More Publications